🔎 Trials Near Me

Home › Macular Edema › Texas

Macular Edema clinical trials in Texas

5 studies for Macular Edema are looking for participants at sites in Texas.

Cities in Texas

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

  • Austin Research Center for Retina, PLLC, Austin
  • Austin Retina Associates, Austin
  • Austin Retina Associates, Austin
  • and 7 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06962839

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

  • Austin Retina Associates ( Site 0008), Austin
  • Retina Consultants of Texas ( Site 0001), Bellaire
  • Retina Consultants of Texas ( Site 0029), Schertz
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07705555

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

  • Texas Retina ( Site 0051), Arlington
  • Texas Retina Associates ( Site 0055), Fort Worth
  • Retina Consultants of Texas - Katy/Cinco Ranch ( Site 0100), Katy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07705607

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

  • Retina Research Institute of Texas, Abilene
  • Austin Retina Associates, PLLC (Austin), Austin
  • UT Austin, Austin
  • and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06990399

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

  • Retina Research Institute of Texas, Abilene
  • Austin Retina Associates, PLLC (Austin), Austin
  • UT Austin, Austin
  • and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06996080

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.